HK1156313A1 - Thienopyridone derivatives as amp-activated protein kinase (ampk) activators amp-(ampk) - Google Patents

Thienopyridone derivatives as amp-activated protein kinase (ampk) activators amp-(ampk)

Info

Publication number
HK1156313A1
HK1156313A1 HK11110571.3A HK11110571A HK1156313A1 HK 1156313 A1 HK1156313 A1 HK 1156313A1 HK 11110571 A HK11110571 A HK 11110571A HK 1156313 A1 HK1156313 A1 HK 1156313A1
Authority
HK
Hong Kong
Prior art keywords
ampk
activators
protein kinase
activated protein
thienopyridone derivatives
Prior art date
Application number
HK11110571.3A
Other languages
English (en)
Chinese (zh)
Inventor
Daniel Cravo
Franck Lepifre
Sophie Hallakou-Bozec
Christine Charon
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40756916&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1156313(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HK1156313A1 publication Critical patent/HK1156313A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK11110571.3A 2008-05-05 2011-10-06 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators amp-(ampk) HK1156313A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08290423 2008-05-05
PCT/EP2009/002606 WO2009135580A1 (en) 2008-05-05 2009-04-08 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators

Publications (1)

Publication Number Publication Date
HK1156313A1 true HK1156313A1 (en) 2012-06-08

Family

ID=40756916

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11110571.3A HK1156313A1 (en) 2008-05-05 2011-10-06 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators amp-(ampk)

Country Status (27)

Country Link
US (1) US8604202B2 (ko)
EP (1) EP2280952B1 (ko)
JP (1) JP5536757B2 (ko)
KR (2) KR101648593B1 (ko)
CN (1) CN102015676B (ko)
AR (1) AR071530A1 (ko)
AU (1) AU2009243811B2 (ko)
BR (1) BRPI0910832B8 (ko)
CA (1) CA2723429C (ko)
CO (1) CO6331304A2 (ko)
CY (1) CY1113112T1 (ko)
DK (1) DK2280952T3 (ko)
EA (1) EA020773B1 (ko)
EC (1) ECSP10010654A (ko)
ES (1) ES2388485T3 (ko)
HK (1) HK1156313A1 (ko)
HR (1) HRP20120549T1 (ko)
IL (1) IL208988A (ko)
MX (1) MX2010011916A (ko)
MY (1) MY160357A (ko)
NZ (1) NZ589690A (ko)
PL (1) PL2280952T3 (ko)
PT (1) PT2280952E (ko)
SI (1) SI2280952T1 (ko)
UA (1) UA103617C2 (ko)
WO (1) WO2009135580A1 (ko)
ZA (1) ZA201008722B (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2552435A1 (en) 2010-04-02 2013-02-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1)
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
BR112013005072B1 (pt) 2010-09-01 2018-09-25 Bayer Intelectual Property Gmbh compostos de cetosultama ou dicetopiridina, composição herbicida compreendendo os mesmos, método para controlar plantas indesejadas e usos dos compostos ou da composição
EP2683690A1 (en) * 2011-03-07 2014-01-15 GlaxoSmithKline LLC Quinolinone derivatives
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
EP2679591A1 (en) * 2012-06-29 2014-01-01 Poxel Thienopyridone derivatives useful as activators of AMPK
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK
EP3089748A4 (en) 2014-01-02 2017-09-27 Massachusetts Eye & Ear Infirmary Treating ocular neovascularization
WO2015114663A1 (en) 2014-01-30 2015-08-06 Council Of Scientific & Industrial Research Novel thieno [2,3-d]pyrimidin-4(3h)-one compounds with antimycobacterial properties
US10308663B2 (en) 2015-06-16 2019-06-04 University Of Virginia Patent Foundation Inhibitors of PTP4A3 for the treatment of cancer
IL283353B (en) * 2015-06-25 2022-09-01 Univ Health Network hpk1 inhibitors and methods of using them
WO2017055925A2 (en) 2015-09-30 2017-04-06 Instituto De Medicina Molecular Methods for attenuating parasite virulence
US11584755B2 (en) 2017-09-26 2023-02-21 Ideaya Biosciences, Inc. Dihydrothieno[3,2-b]pyridine compounds
WO2019106087A1 (en) * 2017-11-29 2019-06-06 Syddansk Universitet Ampk inhibitors
EP4153589A4 (en) 2020-05-19 2024-06-12 Kallyope, Inc. AMPK ACTIVATORS
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂
JP2023544026A (ja) 2020-09-30 2023-10-19 バイオベラティブ セラピューティクス インコーポレイテッド Ampk活性化因子及びその使用方法
WO2022106892A1 (en) 2020-11-17 2022-05-27 Instituto De Medicina Molecular Anti-malarial compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
DE4444815A1 (de) * 1994-12-15 1996-06-20 Merck Patent Gmbh Thienopyridone
AR040123A1 (es) * 2002-05-31 2005-03-16 Upjohn Co Compuestos tiofeno, antihelminticos e insecticidas
US7119205B2 (en) * 2003-05-16 2006-10-10 Abbott Laboratories Thienopyridones as AMPK activators for the treatment of diabetes and obesity
WO2006093518A2 (en) * 2004-06-25 2006-09-08 Apath, Llc Thienyl compounds for treating virus-related conditions
US7563813B2 (en) * 2005-05-13 2009-07-21 Wyeth Iminothiazolidinone derivatives as SFRP-1 antagonists
EP1754483A1 (en) * 2005-08-18 2007-02-21 Merck Sante Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
WO2007072094A1 (en) 2005-12-20 2007-06-28 Richter Gedeon Nyrt. New compounds
CA2721025C (en) * 2008-04-11 2016-07-26 Merck Patent Gmbh Thienopyridone derivatives as amp-activated protein kinase (ampk) activators

Also Published As

Publication number Publication date
CN102015676A (zh) 2011-04-13
JP5536757B2 (ja) 2014-07-02
IL208988A (en) 2016-02-29
EA201001733A1 (ru) 2011-06-30
MX2010011916A (es) 2010-11-26
PL2280952T3 (pl) 2012-10-31
EP2280952B1 (en) 2012-06-27
KR20110010757A (ko) 2011-02-07
ECSP10010654A (es) 2011-01-31
BRPI0910832B1 (pt) 2020-09-15
DK2280952T3 (da) 2012-07-23
UA103617C2 (ru) 2013-11-11
NZ589690A (en) 2012-07-27
AR071530A1 (es) 2010-06-23
US8604202B2 (en) 2013-12-10
AU2009243811A1 (en) 2009-11-12
ZA201008722B (en) 2012-01-25
BRPI0910832A8 (pt) 2016-07-12
SI2280952T1 (sl) 2012-09-28
KR101648593B1 (ko) 2016-08-16
BRPI0910832B8 (pt) 2021-05-25
WO2009135580A1 (en) 2009-11-12
IL208988A0 (en) 2011-01-31
EP2280952A1 (en) 2011-02-09
EA020773B1 (ru) 2015-01-30
PT2280952E (pt) 2012-09-28
CO6331304A2 (es) 2011-10-20
KR20160038065A (ko) 2016-04-06
CN102015676B (zh) 2014-05-28
AU2009243811B2 (en) 2014-04-10
CA2723429A1 (en) 2009-11-12
CY1113112T1 (el) 2016-04-13
HRP20120549T1 (hr) 2012-07-31
MY160357A (en) 2017-02-28
ES2388485T3 (es) 2012-10-15
US20110060001A1 (en) 2011-03-10
JP2011519876A (ja) 2011-07-14
BRPI0910832A2 (pt) 2015-08-11
CA2723429C (en) 2016-10-11

Similar Documents

Publication Publication Date Title
HK1155955A1 (en) Thienopyridone derivatives as amp-activated protein kinase (ampk) activators amp-(ampk)
HK1156313A1 (en) Thienopyridone derivatives as amp-activated protein kinase (ampk) activators amp-(ampk)
HK1158947A1 (en) Macrocyclic pyrimidines as protein kinase inhibitors
SI2201012T1 (sl) Derivati pirolo(2,3-D)pirimidina kot inhibitorji proteina kinaze B
ZA201100344B (en) Pyrimidine derivatives as kinase inhibitors
IL189194A0 (en) Substituted benzimidazoles as kinase inhibitors
HK1146042A1 (en) Pyrimidine derivatives as protein kinase inhibitors
IL207099A0 (en) 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of-??-secretase (bace)
ZA201006104B (en) Substituted xanthine derivatives
HK1151291A1 (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
IL210172A0 (en) Substituted pyrimidin-4-one derivatives
PL2231642T3 (pl) Pirymidyny jako inhibitory kinazy
IL212755A0 (en) Pyrazinopyrazines and derivatives as kinase inhibitors
IL212842A0 (en) Azaindole derivatives as kinase inhibitors
ZA200800506B (en) Substituted benzimidazoles as kinase inhibitors
IL213210A0 (en) Arylcyclopropylacetamide derivatives useful as glucokinase activators